Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et al

Arthritis Rheumatol. 2019 Oct;71(10):1770-1771. doi: 10.1002/art.41016. Epub 2019 Aug 29.

Authors

Elena Gonzalez-Rodriguez¹, Bérengère Aubry-Rozier¹, Delphine Stoll¹, Olivier Lamy¹

Affiliation

¹ Lausanne University Hospital, Lausanne, Switzerland.

PMID: 31215777
DOI: 10.1002/art.41016

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Density Conservation Agents*
Denosumab
Diphosphonates
Double-Blind Method
Glucocorticoids
Humans
Osteoporosis*
Risedronic Acid

Substances

Bone Density Conservation Agents
Diphosphonates
Glucocorticoids
Denosumab
Risedronic Acid